Clinical Trial Details
Braintumor Website

[Information provided by: ClinicalTrials.gov, which provides patients, family members, and members of the public easy and free access to information on clinical studies for a wide range of diseases and conditions.]

NCT02022384 : Immunophenotyping From Blood of Patients With Malignant Gliomas
Phase
AgesMin: 18 Years Max: N/A
Eligibility
Inclusion Criteria:

- patients with glioblastoma or anaplastic astrocytoma

- legal age

- planned chemoradiation and adjuvant chemotherapy (according to Stupp et. al.)

Exclusion Criteria:

- Fertile patients who refuse effective contraception during study treatment

- persistent drug and/or alcohol abuse

- patients not able or willing to behave according to study protocol

- patients in care

- patients that are not able to speak German
LinksPermanent Link to THIS page: https://virtualtrials.com/nct/display1trial.cfm?nct=NCT02022384      |      Link to official Clinicaltrials.gov listing
Locations



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2019 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740